Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,105 USD | -.--% | -.--% | -.--% |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Cordyceps Related Products
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -45,01% |
Verkoop per regio
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Taiwan and Hong Kong
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -45,01% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30-01-17 |
Shi Ming Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Shi Tao Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30-01-17 |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 60 042 000 | 30 042 000 ( 50,03 %) | 0 | 50,03 % |
Bedrijfsgegevens
Acro Biomedical Co. Ltd.
12175 Visionary Way Suite 1160
46038, Fishers
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 6,3 mln. | |
+17,39% | 8,48 mld. | |
+6,26% | 7,6 mld. | |
+7,55% | 6,39 mld. | |
-5,30% | 3,75 mld. | |
-7,57% | 3,71 mld. | |
-1,78% | 1,36 mld. | |
-27,39% | 1,11 mld. | |
+18,29% | 1,02 mld. | |
-9,48% | 924 mln. |
- Beurs
- Aandelen
- Koers ACBM
- Onderneming Acro Biomedical Co., Ltd.